247 Recruiting Ovarian Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Ovarian Cancer
Related Conditions
Top Recruiting Ovarian Cancer Studies
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
📍 City of Hope — Duarte, California
View Study & Checklist ➔Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔NeoVax With Nivolumab in Patients With Ovarian Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
📍 Honor Health — Scottsdale, Arizona
View Study & Checklist ➔A Trial of Vigil for Participants With Ovarian Cancer
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
📍 Cedars Sinai — West Hollywood, California
View Study & Checklist ➔Genetic Testing in African Americans
📍 Georgia Cancer Center at Augusta University — Augusta, Georgia
View Study & Checklist ➔A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Depression Treatment and Screening in Ovarian Cancer Patients
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Nudge to Gynecologic Oncology
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
📍 Cancer Treatment Centers of America, Phoenix. 403 — Goodyear, Arizona
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
📍 UCSF Helen Diller Family CCC — San Francisco, California
View Study & Checklist ➔Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
📍 Research Site — Stanford, California
View Study & Checklist ➔Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
View Study & Checklist ➔Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
📍 Usa Mitchell Cancer Institute /ID# 269661 — Mobile, Alabama
View Study & Checklist ➔Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔A Study of Intra-operative Imaging in Women With Ovarian Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
📍 HonorHealth ( Site 0041) — Phoenix, Arizona
View Study & Checklist ➔PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔D9319C00001- 1L OC Mono Global RCT
📍 Research Site — Santiago,
View Study & Checklist ➔A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
📍 Arizona Oncology Associates, PC - NAHOA — Prescott, Arizona
View Study & Checklist ➔EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
📍 Research Site — Boca Raton, Florida
View Study & Checklist ➔Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer
📍 Abramson Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
📍 Research Site — Boston, Massachusetts
View Study & Checklist ➔BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
📍 University of Illinois Chicago — Chicago, Illinois
View Study & Checklist ➔Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
📍 NorthShore University HealthSystem — Evanston, Illinois
View Study & Checklist ➔Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
📍 UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab
📍 Medical University of South Carolina Hollings Cancer Center — Charleston, South Carolina
View Study & Checklist ➔A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔PITCH - Impacting Hereditary Cancer Testing
📍 University of Kentucky — Lexington, Kentucky
View Study & Checklist ➔Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
📍 Mt. Sinai Comprehensive Cancer Center — Miami, Florida
View Study & Checklist ➔Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔